• The Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko

  • Oct 29 2024
  • Length: 27 mins
  • Podcast

The Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko

  • Summary

  • Episode Highlights
    0:15
    Intro
    1:10 Introducing the Lung Health Cohort Research Study
    3:49 The enrollment strategy
    7:10 Seeking “the cholesterol of lung disease”
    11:50 The role of industry support
    14:09 Imaging strategies for long-term lung assessment
    17:59 Recruitment challenges
    23:05 Final thoughts
    26:20 Outro

    For our 50th episode, Ravi Kalhan, MD, of Northwestern Medicine, George Washko, MD, of Harvard University, and Amy Olson, MD, Executive Director of Medical Affairs for Boehringer Ingelheim Pharmaceuticals, Inc, join us for a panel discussion around improving patient outcomes through innovative lung health research, such as with the American Lung Association Lung Health Cohort Research Study.

    Tune in to learn more about their collaborative efforts to help identify biomarkers and lifestyle patterns for more accurate identification of disease processes, ideally at onset.

    Want more Lungcast? Visit us at HCPLive.com/podcasts/lungcast or www.lung.org/professional-education/lungcast
    Show More Show Less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about The Quest to Intercept Lung Disease with Drs. Ravi Kalhan, Amy Olson & George Washko

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.